|
 |
| Adolor |
Exton, PA |
Developer of novel biopharmaceutical products to treat pain and to relieve the side effects of current pain medications.
Ticker: ADLR
|
|
|
|
|
| Allos Therapeutics |
Westminster, Co |
Biopharmaceuticals / oxygen delivery drugs.
Ticker: ALTH
|
|
|
|
|
| Aradigm
|
Hayward, CA
|
Pulmonary drug delivery devices.
Ticker: ARDM
|
|
|
|
|
| Aspreva Pharmaceuticals |
Victoria, B.C.
Canada
|
Therapies for autoimmune diseases.
| | |
|
|
| AtheroGenics |
Alpharetta, GA |
Cardiovascular pharmaceuticals.
Ticker: AGIX
|
|
|
|
|
| Barrier Therapeutics |
Princeton, NJ |
Pharmaceutical company focused on developing
and commercializing products in the field of dermatology.
Ticker: BTRX
|
|
|
|
|
| Cellgate, Inc. |
Redwood City, CA |
Oncology-focused pharmaceuticals.
|
|
|
|
|
| Cephalon
|
Frazer, PA
|
Approved drug for excessive daytime sleepiness.
Ticker: CEPH
|
|
|
|
|
| Cerexa |
Alameda, CA
|
Development and commercialization of therapies for serious, life-threatening infections.
Acquired by Forest Laboratories.
| | |
|
|
| Connetics
|
Palo Alto, CA
|
Drugs for rheumatology & dermatology.
Acquired by Stiefel Laboratories.
|
|
|
|
|
| Corixa
|
Seattle, WA
|
Developer of immunotherapeutics.
Acquired by GlaxoSmithKline.
|
|
|
|
|
| Ilypsa, Inc. |
Santa Clara, CA
|
Developer of renal-care focused
therapeutics.
Acquired by Amgen.
|
|
|
|
|
| IntraBiotics Pharmaceuticals
|
Sunnyvale, CA
|
Anti-infective drugs.
Ticker: IBPI
|
|
|
|
|
| Nuvelo, Inc. |
Sunnyvale, CA
|
Life improving therapeutics for the treatment of human disease. Merged from Variagenics.
Ticker: NUVO
|
|
|
|
|
| Onyx Pharmaceutical |
Emeryville, CA
|
Molecular oncology.
Ticker: ONXX
|
|
|
|
|
| Selective Genetics
|
San Diego, CA
|
Site specific gene therapeutics and DNA devices for tissue repair and regeneration.
|
|
|
|
|
| SGX Pharmaceuticals, Inc. |
San Diego, CA |
Structure guided drug discovery company accelerating the discovery of novel therapeutics to treat human diseases.
Ticker: SGXP
|
|
|
|
|
| Sirna Therapeutics |
Boulder, CO
|
Biopharmaceutical company focused on developing RNA interference (RNAi) based therapeutics.
Acquired by Merck & Co.
|
|
|
